Auriga Downgrades Salix Pharmaceuticals (SLXP) to Hold
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Auriga downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Hold, price target lowered from $54 to $51.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $50.01 yesterday.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $50.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIBC Downgrades Bank of Montreal (BMO:CN) (BMO) to Neutral
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
